Liu Lin, Yang Xinyu, Gu Yiyu, Jiang Tingbo, Xu Jialiang, Xu Mingzhu
Department of Cardiology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Front Physiol. 2021 Feb 24;12:596548. doi: 10.3389/fphys.2021.596548. eCollection 2021.
Patients with acute fulminant myocarditis often have more adverse cardiovascular events and higher mortality. The purpose of this study was to evaluate the usefulness of age, creatinine, and left ventricular ejection fraction (ACEF score), in determining the risk that acute fulminant myocarditis will lead to serious cardiovascular events, death, and cardiac dysfunction.
We retrospectively reviewed the demographics, laboratory tests, medications, echocardiographic examinations, in-hospital clinical outcomes, major adverse cardiovascular events (MACE), and survival rate at 1 year in the medical records of 220 consecutive subjects suffering from acute fulminant myocarditis from January 2013 to June 2019.
Two hundred twenty patients were divided into a survivor group and a non-survivor group. This study found that patients in the non-survivor group were older, had higher heart rates, and had more serious injuries to multiple organ functions. A high ACEF score at admission was independently associated with an unfavorable prognosis, and it was a predictor of in-hospital mortality. The current analysis extends the predictive performance of the ACEF scores at 30 days by evaluating echocardiographic data as applied to survivors of fulminant myocarditis and cumulative rates of MACE at 1 year. The results indicated that patients with high ACEF scores had poor recovery of cardiac function, and higher rates of MACE, all-cause death, and heart failure at 1 year than the low-ACEF group.
The ACEF score was identified as an effective predictor of poor in-hospital outcomes, worse cardiac recovery after 30 days, and higher rates of MACE, all-cause death, and heart failure at 1 year in patients who had acute fulminant myocarditis. These data suggest that its predictive accuracy means the ACEF score could be used to assess the prognosis of patients with acute fulminant myocarditis.
急性暴发性心肌炎患者常发生更多不良心血管事件且死亡率更高。本研究的目的是评估年龄、肌酐和左心室射血分数(ACEF评分)在确定急性暴发性心肌炎导致严重心血管事件、死亡和心脏功能障碍风险方面的有用性。
我们回顾性分析了2013年1月至2019年6月连续220例急性暴发性心肌炎患者的病历,包括人口统计学资料、实验室检查、用药情况、超声心动图检查、住院临床结局、主要不良心血管事件(MACE)及1年生存率。
220例患者分为存活组和非存活组。本研究发现,非存活组患者年龄更大、心率更高,多器官功能损伤更严重。入院时高ACEF评分与不良预后独立相关,是住院死亡率的预测指标。当前分析通过评估应用于暴发性心肌炎幸存者的超声心动图数据以及1年时MACE的累积发生率,扩展了ACEF评分在30天时的预测性能。结果表明,高ACEF评分患者的心脏功能恢复较差,1年时MACE、全因死亡和心力衰竭的发生率高于低ACEF评分组。
ACEF评分被确定为急性暴发性心肌炎患者住院结局不良、30天后心脏恢复较差以及1年时MACE、全因死亡和心力衰竭发生率较高的有效预测指标。这些数据表明,其预测准确性意味着ACEF评分可用于评估急性暴发性心肌炎患者的预后。